A pilot and feasibility analysis of serum TMAO and choline in a randomized sample from the COSMOS trial.
- 2025
- RCT · n = 40
- Food & function 16(22)
- Irene Sánchez Gavilán
- Sidong Li
- Michael G Sweet
- Juanita G Ratliff
- Pamela M Rist
- Eunjung Kim
- JoAnn E Manson
- Howard D Sesso
- Andrew P Neilson
- PubMed: 41127993
- DOI: 10.1039/d5fo02596f
- High evidence
- Rigorous Journal
- Elderly
the group assigned CE showed trends toward higher levels of choline (0.84 (-1.57, 3.25)) at year 1, but the between-group differences in the 1 year changes in choline were again not statistically significant (2.23 [95% CI, (-1.31, 5.78)]; P = 0.21).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 500 mg/day flavanols